Nektar Therapeutics (NASDAQ:NKTR)

83.38
BATS BZX Real-Time Price
As of 11:48am ET
 -2.83 / -3.28%
Today’s Change
17.33
Today|||52-Week Range
111.36
+39.62%
Year-to-Date

Today’s Trading

Previous close86.21
Today’s open85.50
Day’s range82.13 - 86.34
Volume54,668
Average volume (3 months)2,851,471
Market cap$17.4B
Data as of 11:48am ET, 04/23/2018

Growth & Valuation

Earnings growth (last year)+43.64%
Earnings growth (this year)-132.26%
Earnings growth (next 5 years)-7.38%
Revenue growth (last year)+86.00%
P/E ratioNM
Price/Sales30.27
Price/Book196.78

Competitors

 Today’s
change
Today’s
% change
ONCESpark Therapeutics I...-1.70-2.09%
AVXSAveXis Inc+0.53+0.26%
XONIntrexon Corp+0.53+2.95%
BPMCBlueprint Medicines ...-2.74-3.34%
Data as of 11:49am ET, 04/23/2018

Financials

Next reporting dateMay 9, 2018
EPS forecast (this quarter)-$0.36
Annual revenue (last year)$307.7M
Annual profit (last year)-$96.7M
Net profit margin-31.42%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Operating Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts